James Fingleton

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

The European respiratory journal

Thorax

BMC pulmonary medicine

Allergy

Capital and Coast District Health Board

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Capital and Coast District Health Board

New Zealand

Clinical Leader Respiratory Medicine :: Respiratory Medicine

Publications

Eve J Denton, Mark Hew, Matthew J Peters, John W Upham, Lakmini Bulathsinhala, Trung N Tran, Neil Martin, Celine Bergeron, Mona Al Ahmad, Alan Altraja, Désirée Erlinda Larenas-Linnemann, Ruth Murray, Carlos Andrés Celis-Preciado, Riyad Al-Lehebi, Manon Belhassen, Mohit Bhutani, Sinthia Z Bosnic-Anticevich, Arnaud Bourdin, Guy G O Brusselle, John Busby, Giorgio Walter Canonica, Enrico Heffler, Kenneth R Chapman, Jérémy Charriot, George C Christoff, Li Ping Chung, Borja García Cosio, Andréanne Côté, Richard W Costello, Breda Cushen, James Fingleton, João Almeida Fonseca, Peter Gerard Gibson, Liam G Heaney, Erick Wan-Chun Huang, Takashi Iwanaga, Alexandra M Nanzer, Mariko Siyue Koh, Lauri A Lehtimäki, Jorge F Maspero, Bassam Mahboub, Andrew N Menzies-Gow, Patrick D Mitchell, Papadopoulos G Nikolaos, Andriana I Papaioannou, Luis A Perez-de-Llano, Diahn-Warng Perng, Paul E Pfeffer, Todor A Popov, Celeste M Porsbjerg, Chin Kook Rhee, Nicholas Roche, J Mark FitzGerald, Sundeep Salvi, Johannes Martin Schmid, Chau-Chyun Sheu, Concetta Sirena, Carlos Arturo Torres-Duque, Laila Salameh, Pujan H Patel, Charlotte Suppli Ulrik, Eileen Wang, Michael E Wechsler, David J Price, null null
Real-world biologics response and super-response in the International Severe Asthma Registry cohort. Allergy (2024)
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ open research 7 (1) (2021)
Christina Baggott, Jo Katherine Hardy, Jenny Sparks, Doñah Sabbagh, Richard Beasley, Mark Weatherall, James Fingleton
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis. Thorax (2021)
Christina Baggott, Helen K Reddel, Jo Hardy, Jenny Sparks, Mark Holliday, Andrew Corin, Barney Montgomery, Jim Reid, Davitt Sheahan, Robert J Hancox, Mark Weatherall, Richard Beasley, James Fingleton, null null
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial. The European respiratory journal 55 (4) (2020)
Christina Baggott, Amy Hai Yan Chan, Sally Hurford, James Fingleton, Richard Beasley, Matire Louise Ngarongoa Harwood, Helen K Reddel, William Mark Magnus Levack
Patient preferences for asthma management: a qualitative study. BMJ open 10 (8) (2020)
Christina Baggott, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Daniela Hall, Alexandra Vohlidkova, Robert J Hancox, Mark Weatherall, James Fingleton, Richard Beasley, null null
Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial. The European respiratory journal 56 (4) (2020)
Christina Baggott, Paul Hansen, Robert J Hancox, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Mark Weatherall, Richard Beasley, Helen K Reddel, James Fingleton, null null
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment. Thorax 75 (10) (2020)
Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton
Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial. Respirology (Carlton, Vic.) 24 (11) (2019)
Vanessa M McDonald, James Fingleton, Alvar Agusti, Sarah A Hiles, Vanessa L Clark, Anne Elizabeth Holland, Guy B Marks, Philip P Bardin, Richard Beasley, Ian D Pavord, Peter A B Wark, Peter Gerard Gibson, null null, null null
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. The European respiratory journal 53 (5) (2019)
Richard Beasley, Irene Braithwaite, James Fingleton, Mark Weatherall
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here? The European respiratory journal 51 (1) (2018)
George Bardsley, Janine Pilcher, Steven McKinstry, Philippa Shirtcliffe, James Berry, James Fingleton, Mark Weatherall, Richard Beasley
Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. BMC pulmonary medicine 18 (1) (2018)
George Bardsley, Peter Daley-Yates, Amanda Baines, Rodger Kempsford, Mathew Williams, Tony Mallon, Irene Braithwaite, Kylie Riddell, Shashidhar Joshi, Philippe Bareille, Richard Beasley, James Fingleton, null null
Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial. Respiratory research 19 (1) (2018)
Ruth Semprini, Nick Shortt, Stefan Ebmeier, Alex Semprini, Rachel Varughese, Cecile T J Holweg, John G Matthews, James Fingleton, Mark Weatherall, Richard Beasley, Irene Braithwaite
Change in biomarkers of type-2 inflammation following severe exacerbations of asthma. Thorax 74 (1) (2018)
Aaron Conway, Elizabeth Tipton, Wei-Hong Liu, Zachary Conway, Kathleen Soalheira, Joanna Sutherland, James Fingleton
Accuracy and precision of transcutaneous carbon dioxide monitoring: a systematic review and meta-analysis. Thorax 74 (2) (2018)

James Fingleton.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

James Fingleton